ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 131 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 1.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $109,000 | -40.4% | 168,011 | 0.0% | 0.00% | – |
| Q4 2021 | $183,000 | +25.3% | 168,011 | +108.3% | 0.00% | – |
| Q3 2021 | $146,000 | +43.1% | 80,656 | +110.6% | 0.00% | – |
| Q2 2021 | $102,000 | -29.7% | 38,305 | -4.6% | 0.00% | – |
| Q1 2021 | $145,000 | +70.6% | 40,172 | +18.8% | 0.00% | – |
| Q4 2020 | $85,000 | -22.0% | 33,804 | -21.8% | 0.00% | – |
| Q3 2020 | $109,000 | -37.0% | 43,202 | -18.1% | 0.00% | – |
| Q2 2020 | $173,000 | +41.8% | 52,729 | +5.3% | 0.00% | – |
| Q1 2020 | $122,000 | -40.5% | 50,065 | +15.2% | 0.00% | – |
| Q4 2019 | $205,000 | +29.7% | 43,448 | +17.6% | 0.00% | – |
| Q3 2019 | $158,000 | -11.7% | 36,940 | +19.9% | 0.00% | – |
| Q2 2019 | $179,000 | +80.8% | 30,805 | +19.1% | 0.00% | – |
| Q1 2019 | $99,000 | +106.2% | 25,865 | 0.0% | 0.00% | – |
| Q4 2018 | $48,000 | -23.8% | 25,865 | +30.6% | 0.00% | – |
| Q3 2018 | $63,000 | -37.0% | 19,811 | -40.1% | 0.00% | – |
| Q2 2018 | $100,000 | -30.1% | 33,070 | -9.4% | 0.00% | – |
| Q1 2018 | $143,000 | -25.9% | 36,507 | -22.3% | 0.00% | – |
| Q4 2017 | $193,000 | -33.2% | 46,963 | 0.0% | 0.00% | – |
| Q3 2017 | $289,000 | +3.6% | 46,963 | +5.2% | 0.00% | – |
| Q2 2017 | $279,000 | +4.5% | 44,655 | +6.3% | 0.00% | – |
| Q1 2017 | $267,000 | +17.6% | 41,989 | -1.1% | 0.00% | – |
| Q4 2016 | $227,000 | +31.2% | 42,452 | +38.4% | 0.00% | – |
| Q3 2016 | $173,000 | -2.3% | 30,670 | -4.3% | 0.00% | – |
| Q2 2016 | $177,000 | -25.3% | 32,062 | 0.0% | 0.00% | – |
| Q1 2016 | $237,000 | +28.8% | 32,062 | +43.5% | 0.00% | – |
| Q4 2015 | $184,000 | -9.4% | 22,341 | 0.0% | 0.00% | – |
| Q3 2015 | $203,000 | +3.0% | 22,341 | +34.9% | 0.00% | – |
| Q2 2015 | $197,000 | +12.6% | 16,564 | +5.7% | 0.00% | – |
| Q1 2015 | $175,000 | +116.0% | 15,671 | 0.0% | 0.00% | – |
| Q4 2014 | $81,000 | +92.9% | 15,671 | 0.0% | 0.00% | – |
| Q3 2014 | $42,000 | – | 15,671 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |